RxDoctor Payments Data

Michael Schrift

Geriatric Psychiatry · Seattle, WANPI 1275530990

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$274,071in research payments, 2019–2025

Across 7 payments — averaging $39,153 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$243K
  • Biogen$31K

How this compares

Too few geriatric psychiatry providers in Washingtonto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$70,521
Medicare patients
214
Services billed
660

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NuplazidPimavanserin Tartrate17$116,767
Rivastigmine69$16,179
Memantine Hcl302$9,367
Donepezil Hcl585$6,526
RivastigmineRivastigmine Tartrate91$5,926
Bupropion XlBupropion Hcl46$3,329
Quetiapine Fumarate156$3,043
Escitalopram Oxalate182$2,208
Mirtazapine77$2,069
Trazodone Hcl127$1,612
Risperidone38$1,418
Sertraline Hcl135$962
Clonazepam41$870
Gabapentin13$675
Olanzapine30$639

Paid to pharmacies, not to this prescriber.

Other geriatric psychiatry in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →